Medicated Confectionery Market by Type (Chewing Gums, Hard Boiled Candies, Pastilles), Labeling (Conventional, Sugar-free), Distribution Channel - Global Forecast 2024-2030
Medicated Confectionery Market by Type (Chewing Gums, Hard Boiled Candies, Pastilles), Labeling (Conventional, Sugar-free), Distribution Channel - Global Forecast 2024-2030
The Medicated Confectionery Market size was estimated at USD 6.28 billion in 2023 and expected to reach USD 6.64 billion in 2024, at a CAGR 6.07% to reach USD 9.50 billion by 2030.
Medicated confectionery refers to a niche category of confectionery products that incorporate active pharmaceutical ingredients meant to alleviate various minor health ailments. These edible items blend the enjoyment of a sweet treat with the functionality of medication, offering consumers a more palatable intake than traditional medicinal products. This segment includes products such as cough drops, throat lozenges, antacid candies, and herbal-infused sweets. These confections typically aim to provide relief from symptoms such as sore throats, coughs, colds, digestive issues, and even nasal congestion. The incorporation of medicinal components, including menthol, eucalyptus oil, peppermint oil, and other herbal extracts, is common, and these are often carefully dosed to ensure both efficacy and safety. Medicated confectionery is primarily used for personal care and healthcare. It is purchased by consumers seeking relief from cold and flu symptoms, sore throats, coughs, or those requiring supplemental vitamins and minerals. Target end-users range from children to the elderly, often preferring these accessible forms over traditional medication due to ease of use and palatable flavors. Medicated confectionery market is growing due to the growing focus on health and wellness, expanding demand for fortified or functional confectionery products, rising demand for active ingredients in confectionery, and increasing cases of allergy and hay fevers. However, the market faces certain challenges, such as a limited adoption rate due to misconceptions about medicated confectioneries and volatility in raw material prices of medicated confectionery ingredients, hindering market growth. On the other hand, innovations in flavor and health ingredients, rising investments in research and development activities, online retailing and wide availability in supermarkets and pharmacies, and collaborating with health apps and platforms to promote medicated confectionery as part of a holistic health regimen are expected to support the medicated confectionery market to grow.
Regional Insights
In the Americas, with a focus on the United States and Canada, the medicated confectionery market thrives due to the high consumer demand for over-the-counter (OTC) throat soothers and mouth fresheners. The U.S. exhibits robust spending on healthcare products, with a tendency toward self-medication for minor ailments, which includes a rise in the purchase of medicated confectionery as a preventive measure. The ongoing urbanization in South America has led to busier lifestyles, where convenience is paramount, and medicated confections are favored for their ease of use and portability. The European Union (EU) market shows a trend towards functional confectionery, blending the lines between health supplements and candies. With a growing preference for natural ingredients, there is a surge in organic and sugar-free offerings in medicated candies across EU countries. Market campaigns often emphasize the health benefits and convenience of such products. The Middle East and Africa (MEA) present emerging markets with an expanding consumer base for medicated confectionery. Consumer concerns about diabetes and general health propel the need for sugar-free alternatives. Innovations and investments are typically geared towards tailoring flavors and ingredients to suit local tastes and dietary restrictions. The APAC countries, including China, Japan, and India, showcase diverse market dynamics in the medicated confectionery sector. China's growing middle class and increased health awareness drive the demand for medicated sweets. Japan's aging population and penchant for functional foods contribute to the market growth, while in India, the prevalence of sore throat-related ailments and a burgeoning youth population fuel the demand for affordable OTC remedies.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the Medicated Confectionery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Growing Demand for Fortified/Functional Confectionery Products
Rising Demand for Active Ingredients in Confectionery
Increasing Cases of Allergy and Hay Fevers
Market Restraints
Limited Adoption Rate Due to Misconception of Medicated Confectioneries
Market Opportunities
Innovations in Flavor and Health Ingredients
Rising Investments in the Research and Development Activities
Market Challenges
Volatility in Raw Material Prices of Medicated Confectionery Ingredients
Market Segmentation Analysis
Type: Growing demand for hard-boiled candies for their prolonged release and efficacy for throat issues
Labeling: Rising popularity of sugar-free options due to growing health consciousness and dietary requirements.
Distribution Channel: Increasing use of online channels due to easy accessibility and convenience
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medicated Confectionery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medicated Confectionery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Apax Funds acquire Bazooka Candy Brands
Apax Partners LLP has acquired Bazooka Candy Brands from The Tornante Company and affiliates of Madison Dearborn Partners. Apax aims to enhance Bazooka's footprint through increased distribution, innovative products, geographical reach, and strategic acquisitions.
Nestlé pledges multi-billion investment into nutritionally-enhanced ranges, including confectionery
Nestlé SA has announced a substantial investment program to infuse between CHF 20-25 billion into enhanced nutritional offerings, focusing on health-conscious confectionery products. Intending to provide consumers with better choices, the company plans to strengthen its responsible marketing practices for indulgent items and cap portion sizes to a maximum of 100 calories.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medicated Confectionery Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medicated Confectionery Market, highlighting leading vendors and their innovative profiles. These include A.L.Simpkin & Co. Ltd., Baker Perkins Limited by Schenck Process Group, Bartek Ingredients Inc., Cargill, Inc., Creasy Foods Ltd., Enorama Pharma AB, Ernest Jackson Ltd., GelStat Corporation, Glanbia PLC, Hamac Food Industries Sdn Bhd, Herbion International Inc. by Kehkashan Group, Lofthouse of Fleetwood Ltd., Lozen Pharma Pvt. Ltd., Lozy's pharmaceuticals, S.L., Mars Incorporated, Mondelez International, Inc., Nestlé S.A. BY Ferrero International S.A., Perfetti Van Melle Group B.V., Piedmont Candy Company, Prince Group, Reckitt Benckiser Group PLC, Skyepharma Production S.A.S., Swan Sweets Pvt. Ltd, Syntegon Technology GmbH, Tereos S.A., and UHA Mikakuto Co.Ltd..
Market Segmentation & Coverage
This research report categorizes the Medicated Confectionery Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Chewing Gums
Hard Boiled Candies
Pastilles
Labeling
Conventional
Sugar-free
Distribution Channel
Convenience Stores
Online Retail
Specialist Stores
Supermarkets & Hypermarkets
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Demand for Fortified/Functional Confectionery Products
5.1.1.2. Rising Demand for Active Ingredients in Confectionery
5.1.1.3. Increasing Cases of Allergy and Hay Fevers
5.1.2. Restraints
5.1.2.1. Limited Adoption Rate Due to Misconception of Medicated Confectioneries
5.1.3. Opportunities
5.1.3.1. Innovations in Flavor and Health Ingredients
5.1.3.2. Rising Investments in the Research and Development Activities
5.1.4. Challenges
5.1.4.1. Volatility in Raw Material Prices of Medicated Confectionery Ingredients
5.2. Market Segmentation Analysis
5.2.1. Type: Growing demand for hard-boiled candies for their prolonged release and efficacy for throat issues
5.2.2. Labeling: Rising popularity of sugar-free options due to growing health consciousness and dietary requirements.
5.2.3. Distribution Channel: Increasing use of online channels due to easy accessibility and convenience
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Medicated Confectionery Market, by Type
6.1. Introduction
6.2. Chewing Gums
6.3. Hard Boiled Candies
6.4. Pastilles
7. Medicated Confectionery Market, by Labeling
7.1. Introduction
7.2. Conventional
7.3. Sugar-free
8. Medicated Confectionery Market, by Distribution Channel
8.1. Introduction
8.2. Convenience Stores
8.3. Online Retail
8.4. Specialist Stores
8.5. Supermarkets & Hypermarkets
9. Americas Medicated Confectionery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Medicated Confectionery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Medicated Confectionery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Apax Funds acquire Bazooka Candy Brands
12.3.2. Nestlé pledges multi-billion investment into nutritionally-enhanced ranges, including confectionery